Company: LRHC
Filing Date: 2025-08-11
Form Type: S-1
Source: 0001213900-25-074405
Chunk: 30

Company: La Rosa Holdings Corp.
Filing Date: 2025-08-11
Form: S-1
Chunk 30
---
 the number of shares of common stock, if any, we ultimately sell to the Selling Stockholder under the Facility, and the sale of common stock under the
Facility may cause the trading price of our common stock to decline.

Investors who buy shares at different times will likely pay different prices, and the sale of the shares of common stock acquired by the Selling Stockholder could cause the price of our common stock to decline.

Pursuant to the Facility, we will have discretion,
subject to market demand, to vary the timing, prices, and numbers of shares sold to the Selling Stockholder. If and when we do elect to sell shares of our
common stock to the Selling Stockholder pursuant to the Facility, after the Selling Stockholder has acquired such shares, the Selling Stockholder may resell all, some or none of such shares at
any time or from time to time in its discretion and at different prices. As a result, investors who purchase shares from the Selling Stockholder in this
offering at different times will likely pay different prices for those shares, and so may experience different levels of dilution and
in some cases substantial dilution and different outcomes in their investment results. Investors may experience a decline in the value
of the shares they purchase from the Selling Stockholder in this offering as a result of future sales made by us to the Selling Stockholder at prices lower than the prices
such investors paid for their shares in this offering. Further, the sale of a substantial number of shares of our common stock by the Selling Stockholder,
or anticipation of such sales, could cause the trading price of our common stock to decline or make it more difficult for us to sell equity
or equity-related securities in the future at a time and at a price that we might otherwise desire.

We may not have access to the full amount available under the Facility with the Selling Stockholder. We may require additional financing to sustain our operations, without which we may not be able to continue operations, and the terms of subsequent financings may adversely impact our stockholders.

We may direct the Selling Stockholder to purchase up to $150,000,000
worth of shares of our common stock in a “regular purchase” (as set forth in the Facility) from time to time under the Facility
over a 36-month period generally in amounts of shares of common stock that vary depending on the closing sale price of our common stock
at the time of sale. Moreover, under certain circumstances as set forth in the Facility, we may,